nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2B—Sorafenib—thyroid cancer	0.199	0.606	CbGbCtD
Pramipexole—HTR2C—Sorafenib—thyroid cancer	0.13	0.394	CbGbCtD
Pramipexole—Abdominal pain upper—Epirubicin—thyroid cancer	0.000321	0.000538	CcSEcCtD
Pramipexole—Migraine—Doxorubicin—thyroid cancer	0.00032	0.000536	CcSEcCtD
Pramipexole—Affect lability—Doxorubicin—thyroid cancer	0.00032	0.000536	CcSEcCtD
Pramipexole—Hypokalaemia—Epirubicin—thyroid cancer	0.000319	0.000536	CcSEcCtD
Pramipexole—Diarrhoea—Sorafenib—thyroid cancer	0.000319	0.000536	CcSEcCtD
Pramipexole—Breast disorder—Epirubicin—thyroid cancer	0.000317	0.000532	CcSEcCtD
Pramipexole—Nasopharyngitis—Epirubicin—thyroid cancer	0.000314	0.000526	CcSEcCtD
Pramipexole—Face oedema—Doxorubicin—thyroid cancer	0.000314	0.000526	CcSEcCtD
Pramipexole—Gastritis—Epirubicin—thyroid cancer	0.000311	0.000521	CcSEcCtD
Pramipexole—Muscular weakness—Epirubicin—thyroid cancer	0.00031	0.000519	CcSEcCtD
Pramipexole—Cardiac arrest—Doxorubicin—thyroid cancer	0.000309	0.000518	CcSEcCtD
Pramipexole—Dizziness—Sorafenib—thyroid cancer	0.000309	0.000518	CcSEcCtD
Pramipexole—Mood swings—Doxorubicin—thyroid cancer	0.000308	0.000516	CcSEcCtD
Pramipexole—Abdominal distension—Epirubicin—thyroid cancer	0.000305	0.000512	CcSEcCtD
Pramipexole—Ataxia—Doxorubicin—thyroid cancer	0.000305	0.000512	CcSEcCtD
Pramipexole—Dysphagia—Epirubicin—thyroid cancer	0.000303	0.000509	CcSEcCtD
Pramipexole—Asthma—Epirubicin—thyroid cancer	0.000303	0.000509	CcSEcCtD
Pramipexole—Influenza—Epirubicin—thyroid cancer	0.000303	0.000509	CcSEcCtD
Pramipexole—Dehydration—Doxorubicin—thyroid cancer	0.000302	0.000507	CcSEcCtD
Pramipexole—Dry skin—Doxorubicin—thyroid cancer	0.000298	0.000499	CcSEcCtD
Pramipexole—Pancreatitis—Epirubicin—thyroid cancer	0.000297	0.000499	CcSEcCtD
Pramipexole—Vomiting—Sorafenib—thyroid cancer	0.000297	0.000498	CcSEcCtD
Pramipexole—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000297	0.000497	CcSEcCtD
Pramipexole—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000297	0.000497	CcSEcCtD
Pramipexole—Hypokalaemia—Doxorubicin—thyroid cancer	0.000296	0.000496	CcSEcCtD
Pramipexole—Angina pectoris—Epirubicin—thyroid cancer	0.000295	0.000496	CcSEcCtD
Pramipexole—Rash—Sorafenib—thyroid cancer	0.000294	0.000494	CcSEcCtD
Pramipexole—Dermatitis—Sorafenib—thyroid cancer	0.000294	0.000493	CcSEcCtD
Pramipexole—Breast disorder—Doxorubicin—thyroid cancer	0.000293	0.000492	CcSEcCtD
Pramipexole—Headache—Sorafenib—thyroid cancer	0.000292	0.00049	CcSEcCtD
Pramipexole—Bronchitis—Epirubicin—thyroid cancer	0.000292	0.000489	CcSEcCtD
Pramipexole—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00029	0.000487	CcSEcCtD
Pramipexole—Gastritis—Doxorubicin—thyroid cancer	0.000287	0.000482	CcSEcCtD
Pramipexole—Muscular weakness—Doxorubicin—thyroid cancer	0.000286	0.00048	CcSEcCtD
Pramipexole—Dysuria—Epirubicin—thyroid cancer	0.000284	0.000476	CcSEcCtD
Pramipexole—Abdominal distension—Doxorubicin—thyroid cancer	0.000283	0.000474	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000282	0.000473	CcSEcCtD
Pramipexole—Dysphagia—Doxorubicin—thyroid cancer	0.000281	0.000471	CcSEcCtD
Pramipexole—Asthma—Doxorubicin—thyroid cancer	0.000281	0.000471	CcSEcCtD
Pramipexole—Influenza—Doxorubicin—thyroid cancer	0.000281	0.000471	CcSEcCtD
Pramipexole—Pollakiuria—Epirubicin—thyroid cancer	0.00028	0.00047	CcSEcCtD
Pramipexole—Nausea—Sorafenib—thyroid cancer	0.000277	0.000465	CcSEcCtD
Pramipexole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000277	0.000464	CcSEcCtD
Pramipexole—Weight increased—Epirubicin—thyroid cancer	0.000276	0.000463	CcSEcCtD
Pramipexole—Pancreatitis—Doxorubicin—thyroid cancer	0.000275	0.000462	CcSEcCtD
Pramipexole—Weight decreased—Epirubicin—thyroid cancer	0.000274	0.00046	CcSEcCtD
Pramipexole—Hyperglycaemia—Epirubicin—thyroid cancer	0.000274	0.000459	CcSEcCtD
Pramipexole—Angina pectoris—Doxorubicin—thyroid cancer	0.000273	0.000459	CcSEcCtD
Pramipexole—Pneumonia—Epirubicin—thyroid cancer	0.000272	0.000456	CcSEcCtD
Pramipexole—Infestation NOS—Epirubicin—thyroid cancer	0.00027	0.000454	CcSEcCtD
Pramipexole—Drowsiness—Epirubicin—thyroid cancer	0.00027	0.000454	CcSEcCtD
Pramipexole—Infestation—Epirubicin—thyroid cancer	0.00027	0.000454	CcSEcCtD
Pramipexole—Bronchitis—Doxorubicin—thyroid cancer	0.00027	0.000453	CcSEcCtD
Pramipexole—Renal failure—Epirubicin—thyroid cancer	0.000266	0.000446	CcSEcCtD
Pramipexole—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000265	0.000445	CcSEcCtD
Pramipexole—Urinary tract infection—Epirubicin—thyroid cancer	0.000263	0.000441	CcSEcCtD
Pramipexole—Conjunctivitis—Epirubicin—thyroid cancer	0.000263	0.000441	CcSEcCtD
Pramipexole—Dysuria—Doxorubicin—thyroid cancer	0.000262	0.00044	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000261	0.000438	CcSEcCtD
Pramipexole—Sweating—Epirubicin—thyroid cancer	0.000259	0.000435	CcSEcCtD
Pramipexole—Pollakiuria—Doxorubicin—thyroid cancer	0.000259	0.000435	CcSEcCtD
Pramipexole—Haematuria—Epirubicin—thyroid cancer	0.000258	0.000433	CcSEcCtD
Pramipexole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000256	0.00043	CcSEcCtD
Pramipexole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000256	0.000429	CcSEcCtD
Pramipexole—Weight increased—Doxorubicin—thyroid cancer	0.000255	0.000428	CcSEcCtD
Pramipexole—Epistaxis—Epirubicin—thyroid cancer	0.000255	0.000428	CcSEcCtD
Pramipexole—Weight decreased—Doxorubicin—thyroid cancer	0.000254	0.000426	CcSEcCtD
Pramipexole—Sinusitis—Epirubicin—thyroid cancer	0.000254	0.000426	CcSEcCtD
Pramipexole—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000253	0.000425	CcSEcCtD
Pramipexole—Pneumonia—Doxorubicin—thyroid cancer	0.000252	0.000422	CcSEcCtD
Pramipexole—Drowsiness—Doxorubicin—thyroid cancer	0.00025	0.00042	CcSEcCtD
Pramipexole—Infestation NOS—Doxorubicin—thyroid cancer	0.00025	0.00042	CcSEcCtD
Pramipexole—Infestation—Doxorubicin—thyroid cancer	0.00025	0.00042	CcSEcCtD
Pramipexole—Bradycardia—Epirubicin—thyroid cancer	0.000247	0.000415	CcSEcCtD
Pramipexole—Renal failure—Doxorubicin—thyroid cancer	0.000246	0.000413	CcSEcCtD
Pramipexole—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000245	0.000411	CcSEcCtD
Pramipexole—Rhinitis—Epirubicin—thyroid cancer	0.000243	0.000408	CcSEcCtD
Pramipexole—Conjunctivitis—Doxorubicin—thyroid cancer	0.000243	0.000408	CcSEcCtD
Pramipexole—Urinary tract infection—Doxorubicin—thyroid cancer	0.000243	0.000408	CcSEcCtD
Pramipexole—Hypoaesthesia—Epirubicin—thyroid cancer	0.000242	0.000405	CcSEcCtD
Pramipexole—Pharyngitis—Epirubicin—thyroid cancer	0.000241	0.000404	CcSEcCtD
Pramipexole—Sweating—Doxorubicin—thyroid cancer	0.00024	0.000402	CcSEcCtD
Pramipexole—Urinary tract disorder—Epirubicin—thyroid cancer	0.00024	0.000402	CcSEcCtD
Pramipexole—Oedema peripheral—Epirubicin—thyroid cancer	0.000239	0.000401	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—thyroid cancer	0.000239	0.0004	CcSEcCtD
Pramipexole—Connective tissue disorder—Epirubicin—thyroid cancer	0.000239	0.0004	CcSEcCtD
Pramipexole—Urethral disorder—Epirubicin—thyroid cancer	0.000238	0.000399	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000237	0.000397	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—thyroid cancer	0.000236	0.000396	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—thyroid cancer	0.000235	0.000394	CcSEcCtD
Pramipexole—Visual impairment—Epirubicin—thyroid cancer	0.000234	0.000392	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—thyroid cancer	0.000229	0.000384	CcSEcCtD
Pramipexole—Eye disorder—Epirubicin—thyroid cancer	0.000227	0.000381	CcSEcCtD
Pramipexole—Tinnitus—Epirubicin—thyroid cancer	0.000226	0.00038	CcSEcCtD
Pramipexole—Flushing—Epirubicin—thyroid cancer	0.000225	0.000378	CcSEcCtD
Pramipexole—Cardiac disorder—Epirubicin—thyroid cancer	0.000225	0.000378	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—thyroid cancer	0.000225	0.000378	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000224	0.000375	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—thyroid cancer	0.000223	0.000374	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000222	0.000372	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000221	0.000371	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000221	0.00037	CcSEcCtD
Pramipexole—Angiopathy—Epirubicin—thyroid cancer	0.00022	0.000369	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—thyroid cancer	0.00022	0.000369	CcSEcCtD
Pramipexole—Immune system disorder—Epirubicin—thyroid cancer	0.000219	0.000368	CcSEcCtD
Pramipexole—Mediastinal disorder—Epirubicin—thyroid cancer	0.000219	0.000367	CcSEcCtD
Pramipexole—Chills—Epirubicin—thyroid cancer	0.000218	0.000365	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—thyroid cancer	0.000217	0.000363	CcSEcCtD
Pramipexole—Alopecia—Epirubicin—thyroid cancer	0.000215	0.00036	CcSEcCtD
Pramipexole—Mental disorder—Epirubicin—thyroid cancer	0.000213	0.000357	CcSEcCtD
Pramipexole—Erythema—Epirubicin—thyroid cancer	0.000211	0.000355	CcSEcCtD
Pramipexole—Malnutrition—Epirubicin—thyroid cancer	0.000211	0.000355	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—thyroid cancer	0.00021	0.000352	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—thyroid cancer	0.000209	0.000351	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—thyroid cancer	0.000209	0.00035	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—thyroid cancer	0.000209	0.00035	CcSEcCtD
Pramipexole—Flatulence—Epirubicin—thyroid cancer	0.000208	0.000349	CcSEcCtD
Pramipexole—Tension—Epirubicin—thyroid cancer	0.000207	0.000348	CcSEcCtD
Pramipexole—Dysgeusia—Epirubicin—thyroid cancer	0.000207	0.000347	CcSEcCtD
Pramipexole—Nervousness—Epirubicin—thyroid cancer	0.000205	0.000344	CcSEcCtD
Pramipexole—Back pain—Epirubicin—thyroid cancer	0.000204	0.000343	CcSEcCtD
Pramipexole—Angiopathy—Doxorubicin—thyroid cancer	0.000204	0.000342	CcSEcCtD
Pramipexole—Muscle spasms—Epirubicin—thyroid cancer	0.000203	0.000341	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—thyroid cancer	0.000203	0.00034	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000202	0.00034	CcSEcCtD
Pramipexole—Chills—Doxorubicin—thyroid cancer	0.000202	0.000338	CcSEcCtD
Pramipexole—Vision blurred—Epirubicin—thyroid cancer	0.000199	0.000334	CcSEcCtD
Pramipexole—Alopecia—Doxorubicin—thyroid cancer	0.000199	0.000333	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—thyroid cancer	0.000197	0.00033	CcSEcCtD
Pramipexole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000196	0.000329	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—thyroid cancer	0.000196	0.000328	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—thyroid cancer	0.000196	0.000328	CcSEcCtD
Pramipexole—Anaemia—Epirubicin—thyroid cancer	0.000195	0.000328	CcSEcCtD
Pramipexole—Agitation—Epirubicin—thyroid cancer	0.000194	0.000326	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—thyroid cancer	0.000193	0.000323	CcSEcCtD
Pramipexole—Tension—Doxorubicin—thyroid cancer	0.000192	0.000322	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—thyroid cancer	0.000192	0.000321	CcSEcCtD
Pramipexole—Malaise—Epirubicin—thyroid cancer	0.000191	0.00032	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—thyroid cancer	0.00019	0.000319	CcSEcCtD
Pramipexole—Vertigo—Epirubicin—thyroid cancer	0.00019	0.000319	CcSEcCtD
Pramipexole—Syncope—Epirubicin—thyroid cancer	0.00019	0.000318	CcSEcCtD
Pramipexole—Leukopenia—Epirubicin—thyroid cancer	0.000189	0.000317	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—thyroid cancer	0.000189	0.000317	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—thyroid cancer	0.000188	0.000315	CcSEcCtD
Pramipexole—Palpitations—Epirubicin—thyroid cancer	0.000187	0.000313	CcSEcCtD
Pramipexole—Loss of consciousness—Epirubicin—thyroid cancer	0.000186	0.000312	CcSEcCtD
Pramipexole—Cough—Epirubicin—thyroid cancer	0.000184	0.000309	CcSEcCtD
Pramipexole—Vision blurred—Doxorubicin—thyroid cancer	0.000184	0.000309	CcSEcCtD
Pramipexole—Convulsion—Epirubicin—thyroid cancer	0.000183	0.000307	CcSEcCtD
Pramipexole—Hypertension—Epirubicin—thyroid cancer	0.000182	0.000306	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000181	0.000304	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—thyroid cancer	0.000181	0.000303	CcSEcCtD
Pramipexole—Chest pain—Epirubicin—thyroid cancer	0.00018	0.000302	CcSEcCtD
Pramipexole—Arthralgia—Epirubicin—thyroid cancer	0.00018	0.000302	CcSEcCtD
Pramipexole—Myalgia—Epirubicin—thyroid cancer	0.00018	0.000302	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—thyroid cancer	0.00018	0.000301	CcSEcCtD
Pramipexole—Anxiety—Epirubicin—thyroid cancer	0.000179	0.000301	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000179	0.0003	CcSEcCtD
Pramipexole—Discomfort—Epirubicin—thyroid cancer	0.000178	0.000298	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—thyroid cancer	0.000176	0.000296	CcSEcCtD
Pramipexole—Dry mouth—Epirubicin—thyroid cancer	0.000176	0.000295	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—thyroid cancer	0.000176	0.000295	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—thyroid cancer	0.000175	0.000294	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—thyroid cancer	0.000175	0.000294	CcSEcCtD
Pramipexole—Confusional state—Epirubicin—thyroid cancer	0.000174	0.000292	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—thyroid cancer	0.000173	0.00029	CcSEcCtD
Pramipexole—Oedema—Epirubicin—thyroid cancer	0.000173	0.000289	CcSEcCtD
Pramipexole—Loss of consciousness—Doxorubicin—thyroid cancer	0.000172	0.000288	CcSEcCtD
Pramipexole—Infection—Epirubicin—thyroid cancer	0.000171	0.000287	CcSEcCtD
Pramipexole—Cough—Doxorubicin—thyroid cancer	0.000171	0.000286	CcSEcCtD
Pramipexole—Shock—Epirubicin—thyroid cancer	0.00017	0.000285	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—thyroid cancer	0.000169	0.000284	CcSEcCtD
Pramipexole—Nervous system disorder—Epirubicin—thyroid cancer	0.000169	0.000284	CcSEcCtD
Pramipexole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000169	0.000283	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—thyroid cancer	0.000169	0.000283	CcSEcCtD
Pramipexole—Tachycardia—Epirubicin—thyroid cancer	0.000168	0.000282	CcSEcCtD
Pramipexole—Skin disorder—Epirubicin—thyroid cancer	0.000168	0.000281	CcSEcCtD
Pramipexole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000167	0.00028	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—thyroid cancer	0.000167	0.000279	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—thyroid cancer	0.000167	0.000279	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—thyroid cancer	0.000167	0.000279	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—thyroid cancer	0.000166	0.000278	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000165	0.000277	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—thyroid cancer	0.000165	0.000276	CcSEcCtD
Pramipexole—Anorexia—Epirubicin—thyroid cancer	0.000164	0.000276	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—thyroid cancer	0.000163	0.000273	CcSEcCtD
Pramipexole—Hypotension—Epirubicin—thyroid cancer	0.000161	0.00027	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—thyroid cancer	0.000161	0.00027	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—thyroid cancer	0.00016	0.000268	CcSEcCtD
Pramipexole—Infection—Doxorubicin—thyroid cancer	0.000159	0.000266	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000157	0.000264	CcSEcCtD
Pramipexole—Shock—Doxorubicin—thyroid cancer	0.000157	0.000263	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000157	0.000263	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000156	0.000262	CcSEcCtD
Pramipexole—Insomnia—Epirubicin—thyroid cancer	0.000156	0.000262	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—thyroid cancer	0.000156	0.000261	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—thyroid cancer	0.000155	0.00026	CcSEcCtD
Pramipexole—Paraesthesia—Epirubicin—thyroid cancer	0.000155	0.00026	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000154	0.000259	CcSEcCtD
Pramipexole—Dyspnoea—Epirubicin—thyroid cancer	0.000154	0.000258	CcSEcCtD
Pramipexole—Somnolence—Epirubicin—thyroid cancer	0.000153	0.000257	CcSEcCtD
Pramipexole—Anorexia—Doxorubicin—thyroid cancer	0.000152	0.000255	CcSEcCtD
Pramipexole—Dyspepsia—Epirubicin—thyroid cancer	0.000152	0.000255	CcSEcCtD
Pramipexole—Decreased appetite—Epirubicin—thyroid cancer	0.00015	0.000252	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—thyroid cancer	0.000149	0.00025	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000149	0.00025	CcSEcCtD
Pramipexole—Fatigue—Epirubicin—thyroid cancer	0.000149	0.000249	CcSEcCtD
Pramipexole—Pain—Epirubicin—thyroid cancer	0.000148	0.000247	CcSEcCtD
Pramipexole—Constipation—Epirubicin—thyroid cancer	0.000148	0.000247	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000145	0.000244	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—thyroid cancer	0.000144	0.000242	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—thyroid cancer	0.000143	0.00024	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—thyroid cancer	0.000142	0.000239	CcSEcCtD
Pramipexole—Feeling abnormal—Epirubicin—thyroid cancer	0.000142	0.000238	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—thyroid cancer	0.000142	0.000238	CcSEcCtD
Pramipexole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000141	0.000237	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—thyroid cancer	0.000141	0.000236	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—thyroid cancer	0.000139	0.000233	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000138	0.000231	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—thyroid cancer	0.000138	0.000231	CcSEcCtD
Pramipexole—Urticaria—Epirubicin—thyroid cancer	0.000137	0.00023	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—thyroid cancer	0.000136	0.000229	CcSEcCtD
Pramipexole—Pain—Doxorubicin—thyroid cancer	0.000136	0.000229	CcSEcCtD
Pramipexole—Abdominal pain—Epirubicin—thyroid cancer	0.000136	0.000229	CcSEcCtD
Pramipexole—Body temperature increased—Epirubicin—thyroid cancer	0.000136	0.000229	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000132	0.000221	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000131	0.000219	CcSEcCtD
Pramipexole—Hypersensitivity—Epirubicin—thyroid cancer	0.000127	0.000213	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—thyroid cancer	0.000127	0.000213	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—thyroid cancer	0.000126	0.000212	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—thyroid cancer	0.000126	0.000212	CcSEcCtD
Pramipexole—Asthenia—Epirubicin—thyroid cancer	0.000124	0.000208	CcSEcCtD
Pramipexole—Pruritus—Epirubicin—thyroid cancer	0.000122	0.000205	CcSEcCtD
Pramipexole—Diarrhoea—Epirubicin—thyroid cancer	0.000118	0.000198	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—thyroid cancer	0.000118	0.000197	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—thyroid cancer	0.000115	0.000192	CcSEcCtD
Pramipexole—Dizziness—Epirubicin—thyroid cancer	0.000114	0.000191	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—thyroid cancer	0.000113	0.000189	CcSEcCtD
Pramipexole—Vomiting—Epirubicin—thyroid cancer	0.00011	0.000184	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—thyroid cancer	0.000109	0.000183	CcSEcCtD
Pramipexole—Rash—Epirubicin—thyroid cancer	0.000109	0.000182	CcSEcCtD
Pramipexole—Dermatitis—Epirubicin—thyroid cancer	0.000109	0.000182	CcSEcCtD
Pramipexole—Headache—Epirubicin—thyroid cancer	0.000108	0.000181	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—thyroid cancer	0.000106	0.000177	CcSEcCtD
Pramipexole—Nausea—Epirubicin—thyroid cancer	0.000102	0.000172	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—thyroid cancer	0.000101	0.00017	CcSEcCtD
Pramipexole—Rash—Doxorubicin—thyroid cancer	0.000101	0.000169	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—thyroid cancer	0.000101	0.000169	CcSEcCtD
Pramipexole—Headache—Doxorubicin—thyroid cancer	0.0001	0.000168	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—thyroid cancer	9.48e-05	0.000159	CcSEcCtD
Pramipexole—HTR2A—Signaling Pathways—CALCA—thyroid cancer	3.01e-05	0.000404	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TERT—thyroid cancer	2.99e-05	0.0004	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—KRAS—thyroid cancer	2.98e-05	0.000399	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NRG1—thyroid cancer	2.95e-05	0.000395	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TERT—thyroid cancer	2.94e-05	0.000394	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HIF1A—thyroid cancer	2.92e-05	0.000391	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NRG1—thyroid cancer	2.91e-05	0.00039	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—KRAS—thyroid cancer	2.89e-05	0.000387	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HIF1A—thyroid cancer	2.86e-05	0.000383	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SST—thyroid cancer	2.85e-05	0.000381	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HIF1A—thyroid cancer	2.81e-05	0.000377	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TERT—thyroid cancer	2.8e-05	0.000376	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—KRAS—thyroid cancer	2.78e-05	0.000373	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CDK1—thyroid cancer	2.77e-05	0.000371	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—RXRA—thyroid cancer	2.75e-05	0.000369	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	2.74e-05	0.000367	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CDK1—thyroid cancer	2.73e-05	0.000365	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HIF1A—thyroid cancer	2.68e-05	0.000359	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—thyroid cancer	2.65e-05	0.000355	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TERT—thyroid cancer	2.64e-05	0.000354	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—NRAS—thyroid cancer	2.62e-05	0.000352	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	2.62e-05	0.000352	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TERT—thyroid cancer	2.61e-05	0.00035	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	2.57e-05	0.000344	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NRG1—thyroid cancer	2.53e-05	0.000339	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—HRAS—thyroid cancer	2.53e-05	0.000339	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HIF1A—thyroid cancer	2.53e-05	0.000339	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NRG1—thyroid cancer	2.52e-05	0.000338	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	2.52e-05	0.000337	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HIF1A—thyroid cancer	2.5e-05	0.000334	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	2.48e-05	0.000332	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—NRAS—thyroid cancer	2.48e-05	0.000332	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—thyroid cancer	2.47e-05	0.000331	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—HRAS—thyroid cancer	2.45e-05	0.000329	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	2.45e-05	0.000328	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—BRAF—thyroid cancer	2.41e-05	0.000324	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—AKT1—thyroid cancer	2.39e-05	0.00032	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—BRAF—thyroid cancer	2.36e-05	0.000317	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—HRAS—thyroid cancer	2.36e-05	0.000317	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	2.36e-05	0.000317	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TERT—thyroid cancer	2.36e-05	0.000316	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—BRAF—thyroid cancer	2.33e-05	0.000312	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CCND1—thyroid cancer	2.3e-05	0.000308	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TERT—thyroid cancer	2.27e-05	0.000305	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TERT—thyroid cancer	2.26e-05	0.000303	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—KRAS—thyroid cancer	2.26e-05	0.000303	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	2.25e-05	0.000302	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—AKT1—thyroid cancer	2.23e-05	0.000299	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—NRAS—thyroid cancer	2.23e-05	0.000299	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NRG1—thyroid cancer	2.22e-05	0.000298	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—BRAF—thyroid cancer	2.22e-05	0.000298	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PTEN—thyroid cancer	2.22e-05	0.000298	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	2.21e-05	0.000296	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TERT—thyroid cancer	2.2e-05	0.000295	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PPARG—thyroid cancer	2.2e-05	0.000295	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—NRAS—thyroid cancer	2.2e-05	0.000295	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NRG1—thyroid cancer	2.19e-05	0.000293	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.18e-05	0.000292	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—AKT1—thyroid cancer	2.17e-05	0.00029	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	2.17e-05	0.00029	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	2.16e-05	0.00029	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PPARG—thyroid cancer	2.14e-05	0.000287	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—KRAS—thyroid cancer	2.13e-05	0.000286	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	2.1e-05	0.000282	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—BRAF—thyroid cancer	2.09e-05	0.000281	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—AKT1—thyroid cancer	2.09e-05	0.00028	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—BRAF—thyroid cancer	2.07e-05	0.000277	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PPARG—thyroid cancer	2.05e-05	0.000275	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	2.03e-05	0.000273	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—thyroid cancer	2.01e-05	0.000269	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TERT—thyroid cancer	2e-05	0.000268	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.99e-05	0.000267	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	1.99e-05	0.000266	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NRAS—thyroid cancer	1.98e-05	0.000266	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.96e-05	0.000263	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.92e-05	0.000257	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—KRAS—thyroid cancer	1.92e-05	0.000257	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.92e-05	0.000257	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.91e-05	0.000256	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.91e-05	0.000255	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—KRAS—thyroid cancer	1.89e-05	0.000254	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	1.88e-05	0.000252	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.88e-05	0.000252	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.87e-05	0.00025	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	1.85e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	1.84e-05	0.000247	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.83e-05	0.000245	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—HRAS—thyroid cancer	1.81e-05	0.000243	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.8e-05	0.000241	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.79e-05	0.00024	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	1.79e-05	0.00024	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.79e-05	0.00024	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.76e-05	0.000236	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	1.76e-05	0.000236	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	1.74e-05	0.000234	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARG—thyroid cancer	1.74e-05	0.000233	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.73e-05	0.000232	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	1.73e-05	0.000232	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCND1—thyroid cancer	1.73e-05	0.000231	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.71e-05	0.000229	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.71e-05	0.000229	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—KRAS—thyroid cancer	1.71e-05	0.000229	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.7e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCND1—thyroid cancer	1.7e-05	0.000228	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.7e-05	0.000227	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.68e-05	0.000226	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.68e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	1.68e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PTEN—thyroid cancer	1.67e-05	0.000223	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.66e-05	0.000222	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.66e-05	0.000222	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.65e-05	0.000221	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.64e-05	0.00022	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PTEN—thyroid cancer	1.64e-05	0.00022	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—HRAS—thyroid cancer	1.63e-05	0.000218	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	1.62e-05	0.000218	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCND1—thyroid cancer	1.62e-05	0.000217	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.61e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.61e-05	0.000216	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—AKT1—thyroid cancer	1.6e-05	0.000214	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.6e-05	0.000214	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.59e-05	0.000212	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.58e-05	0.000212	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PTEN—thyroid cancer	1.56e-05	0.00021	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.56e-05	0.00021	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.56e-05	0.000209	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCND1—thyroid cancer	1.53e-05	0.000205	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	1.53e-05	0.000205	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.52e-05	0.000203	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—thyroid cancer	1.52e-05	0.000203	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTEN—thyroid cancer	1.51e-05	0.000202	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.51e-05	0.000202	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.51e-05	0.000202	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NRAS—thyroid cancer	1.49e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PTEN—thyroid cancer	1.48e-05	0.000198	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTEN—thyroid cancer	1.47e-05	0.000197	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NRAS—thyroid cancer	1.46e-05	0.000196	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.46e-05	0.000195	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.45e-05	0.000195	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HRAS—thyroid cancer	1.45e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.45e-05	0.000194	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—AKT1—thyroid cancer	1.44e-05	0.000193	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.42e-05	0.000191	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.42e-05	0.00019	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.42e-05	0.00019	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.41e-05	0.000189	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTEN—thyroid cancer	1.41e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.4e-05	0.000188	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NRAS—thyroid cancer	1.4e-05	0.000187	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.39e-05	0.000187	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.37e-05	0.000183	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.36e-05	0.000183	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.36e-05	0.000182	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	1.36e-05	0.000182	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.36e-05	0.000182	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	1.32e-05	0.000177	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NRAS—thyroid cancer	1.32e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.31e-05	0.000176	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.31e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.31e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.31e-05	0.000175	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.3e-05	0.000174	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.3e-05	0.000174	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.28e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—AKT1—thyroid cancer	1.28e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.28e-05	0.000171	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	1.27e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.27e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.26e-05	0.000169	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—KRAS—thyroid cancer	1.26e-05	0.000169	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.24e-05	0.000166	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.23e-05	0.000165	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.23e-05	0.000165	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	1.23e-05	0.000165	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.21e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—KRAS—thyroid cancer	1.2e-05	0.000161	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	1.2e-05	0.000161	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.2e-05	0.00016	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTEN—thyroid cancer	1.19e-05	0.00016	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.18e-05	0.000158	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	1.17e-05	0.000157	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.16e-05	0.000156	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.15e-05	0.000155	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—thyroid cancer	1.14e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.14e-05	0.000152	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.13e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.13e-05	0.000152	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.13e-05	0.000151	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—thyroid cancer	1.12e-05	0.00015	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—KRAS—thyroid cancer	1.12e-05	0.00015	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.11e-05	0.000149	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.11e-05	0.000149	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.1e-05	0.000148	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.1e-05	0.000147	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	1.1e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HRAS—thyroid cancer	1.09e-05	0.000146	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.09e-05	0.000146	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.07e-05	0.000144	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HRAS—thyroid cancer	1.07e-05	0.000143	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.07e-05	0.000143	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—thyroid cancer	1.07e-05	0.000143	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1.03e-05	0.000138	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HRAS—thyroid cancer	1.02e-05	0.000137	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	1.01e-05	0.000135	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—thyroid cancer	1.01e-05	0.000135	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	9.97e-06	0.000134	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NRAS—thyroid cancer	9.94e-06	0.000133	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—thyroid cancer	9.94e-06	0.000133	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—AKT1—thyroid cancer	9.8e-06	0.000131	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NRAS—thyroid cancer	9.78e-06	0.000131	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KRAS—thyroid cancer	9.74e-06	0.000131	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	9.73e-06	0.00013	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KRAS—thyroid cancer	9.69e-06	0.00013	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HRAS—thyroid cancer	9.63e-06	0.000129	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—AKT1—thyroid cancer	9.6e-06	0.000129	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HRAS—thyroid cancer	9.5e-06	0.000127	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—AKT1—thyroid cancer	9.45e-06	0.000127	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	9.43e-06	0.000126	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—AKT1—thyroid cancer	9.02e-06	0.000121	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—thyroid cancer	8.97e-06	0.00012	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	8.9e-06	0.000119	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AKT1—thyroid cancer	8.7e-06	0.000117	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—thyroid cancer	8.66e-06	0.000116	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—thyroid cancer	8.61e-06	0.000115	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	8.58e-06	0.000115	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KRAS—thyroid cancer	8.55e-06	0.000115	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—AKT1—thyroid cancer	8.5e-06	0.000114	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AKT1—thyroid cancer	8.46e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KRAS—thyroid cancer	8.42e-06	0.000113	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—AKT1—thyroid cancer	8.39e-06	0.000112	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—thyroid cancer	8.38e-06	0.000112	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HRAS—thyroid cancer	8.28e-06	0.000111	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HRAS—thyroid cancer	8.24e-06	0.00011	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AKT1—thyroid cancer	8.11e-06	0.000109	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	8.01e-06	0.000107	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	7.66e-06	0.000103	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—thyroid cancer	7.6e-06	0.000102	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	7.57e-06	0.000102	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—thyroid cancer	7.48e-06	0.0001	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—AKT1—thyroid cancer	7.31e-06	9.8e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—AKT1—thyroid cancer	7.27e-06	9.75e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HRAS—thyroid cancer	7.27e-06	9.74e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HRAS—thyroid cancer	7.15e-06	9.59e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	7.08e-06	9.48e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AKT1—thyroid cancer	6.87e-06	9.21e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—thyroid cancer	6.81e-06	9.12e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	6.51e-06	8.72e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—AKT1—thyroid cancer	6.42e-06	8.6e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—AKT1—thyroid cancer	6.32e-06	8.47e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	5.75e-06	7.7e-05	CbGpPWpGaD
